ACCESSION: MSBNK-SMB_Measured-HSA001P0282004
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 19
COMMENT: RAW_SPEC {'16_posi_14376': {'bp': 676057.0, 'sum': 1785434.0}, '18_posi_14378': {'bp': 658000.0, 'sum': 1687932.0}, '14_posi_14374': {'bp': 611321.0, 'sum': 1572081.0}, '15_posi_14378': {'bp': 501892.0, 'sum': 1371871.0}, '17_posi_14376': {'bp': 495784.0, 'sum': 1319884.0}, '3_posi_14373': {'bp': 322774.0, 'sum': 954685.0}, '10_posi_14375': {'bp': 296712.0, 'sum': 828967.0}, 'BLK01_14395': {'bp': 242013.0, 'sum': 720885.0}, '9_posi_14373': {'bp': 239247.0, 'sum': 654729.0}, '4_posi_14375': {'bp': 236838.0, 'sum': 759315.0}, '12_posi_14377': {'bp': 235393.0, 'sum': 638148.0}, '13_posi_14376': {'bp': 200285.0, 'sum': 551211.0}, '6_posi_14375': {'bp': 183354.0, 'sum': 519018.0}, '5_posi_14375': {'bp': 182342.0, 'sum': 542655.0}, '19_posi_14416': {'bp': 176149.0, 'sum': 540430.0}, 'ProcedureBlank_14374': {'bp': 176139.0, 'sum': 597220.0}, '7_posi_14375': {'bp': 143550.0, 'sum': 446964.0}, '11_posi_14376': {'bp': 141363.0, 'sum': 458263.0}, '8_posi_14376': {'bp': 118162.0, 'sum': 461943.0}}
COMMENT: RETENTION_TIME_STDEV 0.019
COMMENT: PRECURSOR_M/Z_RAW 282.278450
COMMENT: PRECURSOR_M/Z_STDEV 0.000091
COMMENT: PRECURSOR_IN_MS1 mz 282.279023; int 26.074; delta(ppm) 1.379687
COMMENT: PROPOSED_CHARGE_STATE +1; mz 283.282320; int 4.925; cor 0.889
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+NH4; mz 299.305512; int 5.276; cor 0.786
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.412; C18H35NO; [M+H]+; delta(ppm) -0.412413
COMMENT: PROPOSED_MF MS-FINDER 3.326; C18H35NO; [M+H]+; delta(ppm) -0.411571
COMMENT: PROPOSED_MF SIRIUS5_Sirius 42.056; C18H35NO; [M+H]+; delta(ppm) -0.411571
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C18H35NO; [M+H]+; delta(ppm) -0.411571
COMMENT: PROPOSED_MF SIRIUS6_Sirius 59.294; C18H35NO; [M+H]+; delta(ppm) -0.411571
COMMENT: PROPOSED_MF SIRIUS6_Sirius 29.657; C16H33N4; [M+H]+; delta(ppm) 4.344960
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C18H35NO; [M+H]+; delta(ppm) -0.411571
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 15.000; FATBGEAMYMYZAF-KTKRTIGZSA-N; C18H35NO; Spectral Match to 9-Octadecenamide, (Z)- from NIST14
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 3.000; AXTGDCSMTYGJND-UHFFFAOYSA-N; C18H35NO; Massbank:LU121202 Laurocapram1-dodecylazepan-2-one
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 2.000; JMXKCYUTURMERF-UHFFFAOYSA-N; C18H35NO; Massbank:AU258701 Dodemorph4-cyclododecyl-2,6-dimethylmorpholine
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; FATBGEAMYMYZAF-UHFFFAOYSA-N; C18H35NO; Oleamide
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.358; FATBGEAMYMYZAF-KTKRTIGZSA-N; [M+H]+; CCCCCCCC\C=C/CCCCCCCC(N)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.841; AXTGDCSMTYGJND-UHFFFAOYSA-N; [M+H]+; CCCCCCCCCCCCN1CCCCCC1=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.461; MXDYUONTWJFUOK-UHFFFAOYSA-N; [M+H]+; CCCCCCCCCCCC(=O)N1CCCCCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.426; UQQQJJFFLGEZOH-YJIZQYKLNA-N; [M+H]+; C[C@@H]1CC[C@@H](CCCCCCCCCO)N2CCC[C@@H]12
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.283; JMXKCYUTURMERF-UHFFFAOYNA-N; [M+H]+; CC1CN(CC(C)O1)C1CCCCCCCCCCC1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.529; FATBGEAMYMYZAF-KTKRTIGZSA-N; [M+H]+; Oleamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.010; UQQQJJFFLGEZOH-YJIZQYKLNA-N; [M+H]+; UNPD52632
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.910; AXTGDCSMTYGJND-UHFFFAOYSA-N; [M+H]+; 1-dodecylazepan-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.910; MXDYUONTWJFUOK-UHFFFAOYSA-N; [M+H]+; 1-(azepan-1-yl)dodecan-1-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.864; JMXKCYUTURMERF-UHFFFAOYNA-N; [M+H]+; dodemorph
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; FATBGEAMYMYZAF-KTKRTIGZSA-N; [M+H]+; Oleamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.274; JMXKCYUTURMERF-UHFFFAOYNA-N; [M+H]+; dodemorph
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.202; AXTGDCSMTYGJND-UHFFFAOYSA-N; [M+H]+; 1-dodecylazepan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.184; UQQQJJFFLGEZOH-YJIZQYKLNA-N; [M+H]+; UNPD52632
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.172; MXDYUONTWJFUOK-UHFFFAOYSA-N; [M+H]+; 1-(azepan-1-yl)dodecan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 4.000; FATBGEAMYMYZAF-KTKRTIGZSA-N; [M+H]+; (Z)-octadec-9-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.181; AXTGDCSMTYGJND-UHFFFAOYSA-N; [M+H]+; 1-dodecylazepan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.368; JMXKCYUTURMERF-UHFFFAOYSA-N; [M+H]+; 4-cyclododecyl-2,6-dimethylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.129; AWIZWICJDMFGHV-SEYXRHQNSA-N; [M+H]+; (Z)-octadec-6-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.448; ZIRUYTCAIISYIG-UHFFFAOYSA-N; [M+H]+; 2-(1-cyclohexylcyclohexyl)oxy-N,N-diethylethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -21.100; FATBGEAMYMYZAF; [M+H]+; Oleamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -170.773; ZKDQTJNTEXCOAF; [M+H]+; Cerebrodiene
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -218.965; MXDYUONTWJFUOK; [M+H]+; Hexamethylenelauramide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -272.514; AXTGDCSMTYGJND; [M+H]+; Tranzone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -276.567; BJQFPPVYNUKSCM; [M+H]+; Oxazole, 4,5-dihydro-2-pentadecyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -303.654; UQQQJJFFLGEZOH; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -357.569; JMXKCYUTURMERF; [M+H]+; Meltatox
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -466.797; KPRYPASTBSLYHQ; [M+H]+; 2-[2-(6,6-dimethyl-4-bicyclo[3.1.1]heptanyl)ethoxy]ethyl-diethyl-methylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.472; FATBGEAMYMYZAF; [M+H]+; Oleamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -139.156; FATBGEAMYMYZAF; [M+H]+; Oleamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -167.480; AWIZWICJDMFGHV; [M+H]+; Petroselinamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -170.204; UNLZURJISCUXHD; [M+H]+; (Z)-7-Octadecenamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -176.547; OGUCZFYSFZIOTN; [M+H]+; Octadec-12-enamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -189.844; RVDPDXRDNDUJHE; [M+H]+; cis-Oleicamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -262.930; ZKDQTJNTEXCOAF; [M+H]+; 3,14-Octadecadien-1-ol, 2-amino-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -310.409; BJQFPPVYNUKSCM; [M+H]+; 2-Pentadecyl-2-oxazoline
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -323.101; MXDYUONTWJFUOK; [M+H]+; Hexahydro-1-lauroyl-1H-azepine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -391.560; AXTGDCSMTYGJND; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -431.519; UQQQJJFFLGEZOH; [M+H]+; 9-(8-methyl-octahydroindolizin-5-yl)nonan-1-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.576; FATBGEAMYMYZAF; [M+H]+; Oleamide
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C18H36N1O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 28.868
MS$FOCUSED_ION: PRECURSOR_M/Z 282.279025
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-001i-0190000000-cc4e2ed4c727b4f72b4b
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  69.0697499 29.9084 69.070375 2.0559 6.97 0.8407 17 f{C5H9}/-1.84ppm,p-C13H27N1O1
  81.0697570 34.9863 81.070283 1.4679 10.75 0.8235 16 f{C6H9}/-1.48ppm,p-C12H27N1O1
  83.0854403 48.4222 83.085944 1.4082 11.81 0.8018 19 f{C6H11}/-1.04ppm,p-C12H25N1O1
  95.0854070 46.1582 95.085767 1.8930 10.60 0.8039 18 f{C7H11}/-1.26ppm,p-C11H25N1O1
  97.1011099 55.5663 97.101455 1.2255 12.62 0.9088 19 f{C7H13}/-0.69ppm,p-C11H23N1O1
  109.1010922 51.5713 109.101329 1.2924 12.30 0.7825 19 f{C8H13}/-0.78ppm,p-C10H23N1O1
  111.1166976 42.6781 111.116913 1.3859 6.74 0.9363 17 f{C8H15}/-1.16ppm,p-C10H21N1O1
  114.0912387 37.9973 114.091421 1.6390 8.95 0.8321 15 f{C6H12N1O1}/-0.89ppm,p-C12H24
  123.1166608 29.0989 123.116729 1.9737 8.91 0.8725 14 f{C9H15}/-1.35ppm,p-C9H21N1O1
  127.1116299 26.9146 127.111642 1.5498 13.35 0.1692 14 f{C8H15O1}/-0.88ppm,p-C10H21N1
  128.1068997 33.5164 128.106897 2.1466 8.24 0.8786 15 f{C7H14N1O1}/-0.71ppm,p-C11H22
  135.1167441 41.5644 135.116652 1.8725 7.67 0.8930 19 f{C10H15}/-0.61ppm,p-C8H21N1O1
  149.1322503 40.3502 149.132149 2.6151 8.59 0.9429 15 f{C11H17}/-1.52ppm,p-C7H19N1O1
  161.1323815 32.8968 161.132272 1.6446 18.37 0.0485 18 f{C12H17}/-0.59ppm,p-C6H19N1O1
  177.1637408 24.8418 177.163621 3.3077 9.62 0.7650 15 f{C13H21}/-0.20ppm,p-C5H15N1O1
  201.1635163 45.3549 201.163382 2.4955 21.57 0.0299 18 f{C15H21}/-1.30ppm,p-C3H15N1O1
  219.1743025 73.6357 219.174157 2.6600 30.76 0.5298 19 f{C15H23O1}/-0.18ppm,p-C3H13N1
  237.1849739 38.3226 237.184817 2.4327 20.04 0.0444 18 ?
  247.2419886 167.9428 247.241826 1.3873 16.97 0.9368 19 f{C18H31}/-0.16ppm,p-H5N1O1
  265.2525714 196.9517 265.252398 1.2328 30.75 0.9281 19 f{C18H33O1}/-0.08ppm,p-H3N1
  282.1914567 139.6221 282.191273 2.1404 65.81 0.0035 19 ?
  282.2278893 272.5273 282.227706 1.4173 130.33 -0.1649 19 ?
  282.2787282 999.0000 282.278545 0.8609 0.00 1.0000 19 f{C18H36N1O1}/-1.46ppm,p
PK$NUM_PEAK: 23
PK$PEAK: m/z int. rel.int.
  69.069750 29.91 29
  81.069757 34.99 34
  83.085440 48.42 48
  95.085407 46.16 46
  97.101110 55.57 55
  109.101092 51.57 51
  111.116698 42.68 42
  114.091239 38.00 37
  123.116661 29.10 29
  127.111630 26.91 26
  128.106900 33.52 33
  135.116744 41.56 41
  149.132250 40.35 40
  161.132382 32.90 32
  177.163741 24.84 24
  201.163516 45.35 45
  219.174303 73.64 73
  237.184974 38.32 38
  247.241989 167.94 167
  265.252571 196.95 196
  282.191457 139.62 139
  282.227889 272.53 272
  282.278728 999.00 999
//
